Skip to content

High-Frequency QRS for Predicting Microvascular Dysfunction and Adverse Events After PCI in Acute Myocardial Infarction: A Prospective, Multicenter Cohort Study

High-Frequency QRS for Predicting Microvascular Dysfunction and Adverse Events After PCI in Acute Myocardial Infarction: A Prospective, Multicenter Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113596
Enrollment
Unknown
Registered
2025-12-01
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

Case series:NA

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Voluntary participation, understanding and signing the informed consent form. 2. Age >= 18 years and <= 75 years, gender unrestricted. 3. Patients who were clinically diagnosed with acute myocardial infarction and successfully underwent PCI surgery;

Exclusion criteria

Exclusion criteria: 1. History of prior myocardial infarction or chronic heart failure; 2. QRS duration >120 ms (including paced rhythm, Wolff-Parkinson-White syndrome, bundle branch block, or left ventricular hypertrophy with repolarization abnormalities); 3. Structural heart diseases (congenital heart disease, cardiomyopathy, aortic dissection, etc.); 4. Persistent atrial fibrillation or malignant arrhythmias; 5. History of intracranial hemorrhage or ischemic stroke within 1 month; 6. Prolonged cardiopulmonary resuscitation or requiring advanced life support; 7. Scheduled for imminent surgical procedure with anticipated inability to complete HF-QRS assessment; 8. Other life-threatening conditions including:Severe hepatic or renal dysfunction ;Uncontrolled systemic diseases ; Hematologic disorders ;Active infections; Concurrent malignancy with life expectancy <1 year; 9. Other investigator-determined exclusionary conditions: Pregnancy ;Current participation in other clinical trials; 10. Declined to participate in the clinical study.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events;

Secondary

MeasureTime frame
echocardiography;NT-ProBNP;coronary angiography-derived index of microcirculatory resistance;Troponin T;Cardiac magnetic resonance;

Countries

China

Contacts

Public ContactYuan Lu

The Affiliated Hospital of Xuzhou Medical University

Luyuan329@163.com+86 516 8580 5192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026